| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Oyler John is a Chief Executive Officer at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2017 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 144,000 | $93.95 | $13,529,286.30 | -5.5% | |
| Nov 29, 2017 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 85,906 | $84.66 | $7,272,904.35 | -6.5% | |
| Nov 15, 2017 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 150,957 | $80.50 | $12,152,373.89 | -3.8% | |
| Jul 6, 2017 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 219,400 | $64.82 | $14,221,124.62 | -18.7% |